Immediate Impact
94 standout
Citing Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Works of B Dodinot being referenced
DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
1996
[Obstructive cardiomyopathy of the left ventricle with complete auriculo-ventriculrar block. Therapeutic considerations].
1968
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| B Dodinot | 278 | 39 | 25 | 44 | 40 | 347 | |
| Joshua R. Silverstein | 148 | 29 | 17 | 55 | 27 | 330 | |
| Tomás Zaremba | 234 | 52 | 6 | 108 | 34 | 391 | |
| E Parsai | 274 | 38 | 15 | 105 | 33 | 361 | |
| Ronen Goldkorn | 208 | 44 | 5 | 71 | 24 | 318 | |
| J. Böhm | 205 | 69 | 8 | 25 | 42 | 402 | |
| Mark Castellani | 257 | 70 | 15 | 103 | 18 | 352 | |
| Steve Axelrod | 121 | 53 | 7 | 72 | 22 | 325 | |
| Robert C. Kline | 141 | 55 | 45 | 189 | 24 | 370 | |
| Vladimír Kincl | 238 | 59 | 8 | 93 | 41 | 361 | |
| Γεώργιος Κόλλιας | 178 | 109 | 6 | 23 | 27 | 346 |
All Works
Loading papers...